It has been reported that EZH2 is highly expressed in various cancer types [95,96,97] and mediates epigenetic silencing by catalyzing the heterochromatin histone mark H3K27me3 at specific loci, which in turn induces changes in gene expression leading to abnormal biological functions [82,83,84,98]. Here, EZH2 is linked to cancer.